vimarsana.com

Oculis Announces First Patient First Visit in Phase 2b RELIEF Trial of Topical Anti-TNFα Licaminlimab (OCS-02) in Dry Eye Disease

Oculis Announces First Patient First Visit in Phase 2b RELIEF Trial of Topical Anti-TNFα Licaminlimab (OCS-02) in Dry Eye Disease

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Paris ,France General ,France ,Boston ,Massachusetts ,United States ,Switzerland ,Sylvia Cheung ,Christophe Baudouin ,Eric Donnenfeld ,Lifesci Advisorscorey Davis ,Oculis Holding ,National Ophthalmology Hospital ,Oculis Holding Ag Nasdaq ,Nasdaq ,Exchange Commission ,Eudes European Dry Eye Society ,Dry Eye Disease ,First Patient Visit ,Chief Executive Officer ,Clinical Professor ,New York University ,Oculis Scientific Advisory Board ,Quinze Vingts National Ophthalmology Hospital ,Sci Advisorscorey Davis ,Risk Factors ,Dry Eye Disease Landscape ,Ocular Surface ,Eye Disease ,Dry Eye Society ,Dry Eye So Difficult ,

vimarsana.com © 2020. All Rights Reserved.